BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.
You must log in to view this page.

Pacific Biosciences of California Inc.

NASDAQ: PACB    
Share price (11/21/24): $1.77    
Market cap (11/21/24): $485 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 8 pages Side Letter Agreement
12/34/56
EX-10.1
from 8-K 7 pages November 7, 2024 A
12/34/56
EX-10.3
from 8-K 24 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.2
from 8-K 22 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Stock Option Agreement Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 20 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.28
from 10-K 6 pages Material contract
12/34/56
EX-10.1
from 8-K 5 pages June 23, 2023 A
12/34/56
EX-10.27
from 10-K 5 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Performance-Based Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.1
from 10-Q 17 pages Background
12/34/56
EX-10.3
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.2
from 8-K 20 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Stock Option Agreement Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 13 pages Pacific Biosciences of California, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 60 pages Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 57 pages Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc
12/34/56
EX-10.6
from 10-Q 2 pages Certain Confidential Information Contained in This Document, Marked by Brackets ([***]), Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.2
from 10-Q 3 pages  March 23, 2021   Michele Farmer   Dear Michele,  on Behalf of Pacific Biosciences of California, Inc. (The “Company”), I Am Pleased to Offer You a Position at the Company as Chief Accounting Officer. You Will Be Reporting to Susan Kim.  You Will Receive a Salary of $295,000 Annually, Paid Twice Monthly According to the Company’s Payroll Schedule. 
12/34/56
EX-10.3
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 37 pages Securities Purchase Agreement Recitals
12/34/56
EX-10.1
from 8-K 114 pages Agreement and Plan of Merger and Plan of Reorganization Among Pacific Biosciences of California, Inc. Apollo Acquisition Corp. Apollo Acquisition Sub, LLC. Omniome, Inc. and Shareholder Representative Services LLC, as Securityholder Representative July 19, 2021
12/34/56